Fitzgeraldo A. Sanchez | MD

Dr. Fitzgeraldo Sánchez comes from a long line of dermatologists. Growing up in Puerto Rico, he witnessed his father, uncle, and cousin practice dermatology with a dedication that would inspire him to follow their in their footsteps. Now a leading practitioner in New York City at Bobby Buka MD, Dr. Sanchez is an expert pathologist, melanoma specialist, and academic and financial advisor for various renowned medical journals and institutions. Dr. Sánchez also offers surgical expertise in MOHS, laser and cosmetics as well as pediatric care.

Dr. Sánchez completed his medical training at the Ponce School of Medicine in Puerto Rico. During that time he completed research projects at the University of Puerto Rico and at the Wellman Laboratories of Photo-Medicine at the Massachusetts General Hospital in Boston, Massachusetts. From 2000 to 2002, Dr. Sanchez researched mechanical devices in dermatology, including cameras that visualize pigmentation to identify cancerous skin cells.

Dr. Fitzgeraldo Sánchez’ dermatology residency was completed at the world renowned Skin and Cancer Unit at New York University, one of the oldest dermatology departments in the U.S.A and arguably one of the best in the world. During his residency, Dr. Sánchez was trained in cosmetic surgery and other principal elements of dermatological practice. 

Dr. Sánchez completed fellowships in melanoma research (Laboratory Medicine) and dermatopathology at the Mayo Clinic Graduate Medical School in Rochester, MN and at SUNY Downstate Medical School in Brooklyn, NY (Ackerman Academy of Dermatopathology). From 2005 to 2006, Dr. Sanchez researched genetic testing for BRAF mutations and melanoma. Studying pathology has helped Dr. Sánchez visualize diseases and understand what is happening underneath his patients’ skin, a skill that has proven extraordinarily beneficial to his role as a practitioner.

Dr. Sánchez is on the editorial board of the Journal of Drugs in Dermatology, and reviews articles for both the American Journal of Dermatopathology and the Journal of the American Academy of Dermatology. As a columnist for Washington Whispers, he reviewed new FDA-approved dermatology drugs to alert practitioners of new treatments in the pipeline so they would know what kind of medical advancements to expect in coming years.

Dr. Fitzgeraldo Sánchez is an active member of the American Academy of Dermatology’s Health Care Finance Committee, for which he reviews general dermatology cases and gives his professional opinion on the reliability and credibility of their methodology and findings. He also belongs to the Puerto Rico Dermatological Society, the Paul O’Leary Society, and Alumni Society of the Mayo Clinic.

Dr. Sánchez represents the American Academy of Dermatology at the AMA/Specialty Society Relative Value Scale Update Committee (RUC), which deals with reimbursements from Medicare. By diligently reviewing codes for medical billing, he works to keep dermatology services, like those patients receive at Bobby Buka MD, from being devalued unnecessarily.

In addition to his work as a practitioner, committee member, and editorial advisor, Dr. Sanchez is a Professor of Dermatology at Weill Cornell Medical Center (New York-Presbyterian), and Mount Sinai Hospital’s Dermatology Department.

As a dermatology practitioner, Dr. Fitzgeraldo Sánchez is excited by the unique stories his patients share. His day-to-day interactions make the job worthwhile, as does the joy of witnessing patients get better through treatment. He does his best to make them each patient feel like an extension of his family by offering his professional opinion in a personalized manner, the same as he would to his mother, sister, or cousin.

Dr. Fitzgeraldo Sánchez is well versed in English and Spanish, and is enthusiastic about serving local communities and the diverse range of patients that come through the door at Bobby Buka MD.